The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
New Paradigms in the Clinical Management of Li–Fraumeni Syndrome
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Multiple subsequent studies from various groups have shown that the protocol does improve patient survival rates [135, 136, 137, 138].”
From The TP53 tumor suppressor gene: From molecular biology to clinical investigations (2025) · cites this paper as [138]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Key challenges for delivering clinical impact with artificial intelligence
Kelly, C. J., Karthikesalingam, A., Suleyman, M., Corrado, G., & King, D. (2019) · BMC Medicine · doi:10.1186/s12916-019-1426-2 · Cited by 3,136
Causability and explainability of artificial intelligence in medicine
Holzinger, A., Langs, G., Denk, H., Zatloukal, K., & Müller, H. (2019) · WIREs Data Mining and Knowledge Discovery · doi:10.1002/widm.1312 · Cited by 1,885
The landscape of genomic alterations across childhood cancers
ICGC PedBrain-Seq Project, Gröbner, S. N., ICGC MMML-Seq Project, Worst, B. C., Weischenfeldt, J., Buchhalter, I., Kleinheinz, K., Rudneva, V. A., Johann, P. D., Balasubramanian, G. P., et al. (2018) · Nature · doi:10.1038/nature25480 · Cited by 1,572
Liu, M. C., Oxnard, G. R., Klein, E. A., Swanton, C., Seiden, M. V., Liu, M. C., Oxnard, G. R., Klein, E. A., Smith, D., Richards, D., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.02.011 · Cited by 1,495
Germline Mutations in Predisposition Genes in Pediatric Cancer
Zhang, J., Walsh, M. F., Wu, G., Edmonson, M. N., Gruber, T. A., Easton, J., Hedges, D., Ma, X., Zhou, X., Yergeau, D. A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1508054 · Cited by 1,345
New Users of Metformin Are at Low Risk of Incident Cancer
Libby, G., Donnelly, L. A., Donnan, P. T., Alessi, D. R., Morris, A. D., & Evans, J. M. M. (2009) · Diabetes Care · doi:10.2337/dc08-2175 · Cited by 996
Sensitive tumour detection and classification using plasma cell-free DNA methylomes
Shen, S. Y., Singhania, R., Fehringer, G., Chakravarthy, A., Roehrl, M. H. A., Chadwick, D., Zuzarte, P. C., Borgida, A., Wang, T. T., Li, T., et al. (2018) · Nature · doi:10.1038/s41586-018-0703-0 · Cited by 983
Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers
Bougeard, G., Renaux-Petel, M., Flaman, J.-M., Charbonnier, C., Fermey, P., Belotti, M., Gauthier-Villars, M., Stoppa-Lyonnet, D., Consolino, E., Brugières, L., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.5728 · Cited by 760
Villani, A., Shore, A., Wasserman, J. D., Stephens, D., Kim, R. H., Druker, H., Gallinger, B., Naumer, A., Kohlmann, W., Novokmet, A., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30249-2 · Cited by 546
Self-citationEnabling Technologies for Personalized and Precision Medicine
Ho, D., Quake, S. R., McCabe, E. R. B., Chng, W. J., Chow, E. K., Ding, X., Gelb, B. D., Ginsburg, G. S., Hassenstab, J., Ho, C.-M., et al. (2020) · Trends in Biotechnology · doi:10.1016/j.tibtech.2019.12.021 · Cited by 517
Research works printed but not linked: 82
- 10.1038/s41467-020-16067-1 · DOI
- 2018, Revising tumor patterns and penetrance in germline TP53 mutations carriers: temporal phases of Li-Fraumeni syndrome, Curr Opin Oncol, 30, 23, 10.1097/CCO.0000000000000423 · DOI · Paper page
- 10.1080/14737159.2017.1275965 · DOI
- 10.1038/ng.2953 · DOI · Paper page
- 2019, Value of molecular classification for prognostic assessment of adrenocortical carcinoma, JAMA Oncol, 5, 1440, 10.1001/jamaoncol.2019.1558 · DOI
- 10.1016/S1470-2045(16)30147-4 · DOI · Paper page
- 10.1001/jamaoncol.2017.1968 · DOI · Paper page
- 10.1093/jnci/djab147 · DOI
- 10.1093/bib/bbab524 · DOI
- 10.1016/j.cell.2017.09.048 · DOI · Paper page
- 10.1038/nature26000 · DOI · Paper page
- Chang A , Suriyakumar VM , Moturu A , Tewattanarat N , Doria A , Goldenberg A . 2020. Using generative models for pediatric wbMRI. http://arxiv.org/abs/2006.00727 · arXiv
- 10.1093/carcin/bgp143 · DOI · Paper page
- 10.1136/jmg.38.1.43 · DOI · Paper page
- 10.18632/oncotarget.4602 · DOI
- 10.1126/science.aar3247 · DOI · Paper page
- 10.18632/aging.100496 · DOI
- 10.6004/jnccn.2017.0003 · DOI · Paper page
- 10.1038/s41416-018-0019-8 · doi:10.1038/s41416-018-0019-8
- 10.1056/NEJMoa1213261 · DOI · Paper page
- 10.1001/jama.2017.14585 · DOI · Paper page
- 10.1038/s41467-020-19175-0 · DOI
- 10.1136/bmj.38415.708634.F7 · DOI · Paper page
- 10.1038/s41598-020-61237-2 · DOI
- 10.1093/carcin/bgx069 · DOI
- 10.1200/JCO.2008.16.6959 · DOI · Paper page
- 10.1158/1940-6207.CAPR-13-0299 · DOI
- 10.1158/1078-0432.CCR-14-3326 · DOI
- 10.1038/nrc4001 · DOI
- 10.1038/ng.2532 · DOI · Paper page
- 10.1016/j.cancergen.2014.12.003 · DOI
- kConFab, 2018, Heritable DNA methylation marks associated with susceptibility to breast cancer, Nat Commun, 9, 867, 10.1038/s41467-018-03058-6 · DOI
- 10.14694/EdBook_AM.2012.32.8 · DOI
- 10.18632/aging.100498 · DOI
- 10.1158/1078-0432.CCR-17-0408 · DOI · Paper page
- 10.21037/atm.2017.01.32 · DOI · Paper page
- 10.1126/science.abb9601 · DOI · Paper page
- 10.1093/jnci/91.12.1051 · DOI · Paper page
- 10.18632/aging.100533 · DOI
- 10.1038/srep29922 · doi:10.1038/srep29922
- 10.1002/cncr.30248 · DOI · Paper page
- 10.1126/science.1978757 · DOI · Paper page
- 10.1200/JCO.2010.31.3577 · DOI
- 10.1038/nrclinonc.2014.41 · DOI · Paper page
- 10.1182/asheducation-2016.1.293 · DOI
- 10.1038/ng.2563 · DOI · Paper page
- 10.1001/jama.2015.10080 · DOI · Paper page
- 10.1016/S1470-2045(08)70038-X · DOI · Paper page
- 10.1038/sj.onc.1207714 · DOI · Paper page
- 10.1148/radiol.2018180237 · DOI · Paper page
- 10.1002/cncr.26390 · DOI · Paper page
- 2003, Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype, Cancer Res, 63, 6643
- 10.4161/cbt.28164 · DOI
- 10.1016/j.cell.2011.12.013 · DOI · Paper page
- 10.1136/jmedgenet-2017-104976 · DOI
- 10.1038/nrclinonc.2014.169 · DOI
- 10.1200/JCO.2016.67.6940 · DOI
- 10.1371/journal.pmed.1002721 · DOI
- 10.1038/ng.2645 · DOI · Paper page
- 10.1158/2159-8290.CD-13-0639 · DOI · Paper page
- 10.1080/01621459.2018.1482749 · DOI
- 10.1158/0008-5472.CAN-19-0725 · DOI
- 10.1158/0008-5472.CAN-19-0728 · DOI
- 10.1073/pnas.0802970105 · DOI · Paper page
- 10.1038/nm.3870 · DOI · Paper page
- 10.1007/s40291-013-0020-0 · DOI
- 10.1038/348747a0 · DOI · Paper page
- 10.1158/2767-9764.CRC-22-0402 · DOI
- 10.1200/JCO.2009.26.8169 · DOI · Paper page
- 2016, Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides, Oncotarget, 7, 11817, 10.18632/oncotarget.7857 · DOI · Paper page
- 10.1038/s41431-020-0638-4 · DOI · Paper page
- 2020, Current medulloblastoma subgroup specific clinical trials, Transl Pediatr, 9, 157, 10.21037/tp.2020.03.03 · DOI
- 10.1200/JCO.2009.22.7967 · DOI · Paper page
- 10.1038/ng.432 · DOI · Paper page
- 10.1016/S1470-2045(11)70119-X · DOI · Paper page
- 10.1038/s43018-022-00474-y · DOI
- 10.1093/jncics/pkaa063 · DOI
- 10.1172/JCI88668 · DOI
- 10.1200/JCO.2013.52.6863 · DOI · Paper page
- 10.1038/s41591-020-1072-4 · DOI · Paper page
- 10.1016/j.gim.2022.01.609 · doi:10.1016/j.gim.2022.01.609
- 10.1016/j.ccell.2016.04.002 · DOI · Paper page
Cited by
The TP53 tumor suppressor gene: From molecular biology to clinical investigations
Baliakas, P., & Soussi, T. (2025) · Journal of Internal Medicine · doi:10.1111/joim.20106 · Cited by 50
Metadata
- Authors
- Giovino, C., Subasri, V., Telfer, F., & Malkin, D.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2024-05-01
- Volume
- 14
- Issue
- 11
- Pages
- a041584
- ISSN
- 2157-1422
- Cited by
- 11
- References
- 15
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: New Paradigms in the Clinical Management of Li–Fraumeni Syndrome. https://app.cochat.ai/papers/10.1101/cshperspect.a041584
- The paper
- Giovino, C., Subasri, V., Telfer, F., & Malkin, D. (2024). New Paradigms in the Clinical Management of Li–Fraumeni Syndrome. Cold Spring Harbor Perspectives in Medicine. https://doi.org/10.1101/cshperspect.a041584
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.